Skip to main content
Clinical Trials/NCT05143762
NCT05143762CompletedPhase 2

Effect of Preemptive Dexamethasone and Paracetamol on Postoperative Period Following Adeno-tosillectomy in Pediatric Age Group-: A Randomized Clinical Trial

Benha University1 site in 1 country90 target enrollmentStarted: October 15, 2021Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
90
Locations
1
Primary Endpoint
Total opioid consumption at PACU

Study Overview

Brief Summary

Tonsillectomy is one of the most common surgical operations performed on children, and it is frequently linked with an increased risk of complications such as acute discomfort when swallowing and postoperative nausea and vomiting (PONV).The most prevalent causes for postponing discharge home are poorly managed pain and PONV.

Detailed Description

Tonsillectomy is one of the most common surgical operations performed on children, and it is frequently linked with an increased risk of complications such as acute discomfort when swallowing and postoperative nausea and vomiting (PONV). The most prevalent causes for postponing discharge home are poorly managed pain and PONV. As a result, these occurrences should be avoided and managed utilizing a multimodal strategy Because of its low cost and adequate safety profile in the treatment of post-tonsillectomy pain, acetaminophen is presently regarded the fundamental analgesic in this situation. Furthermore, acetaminophen has been recommended for use in children, and its pharmacological safety in this age group has been shown. Dexamethasone is another medication that is used to reduce postoperative pain and PONV in various procedures.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
3 Years to 16 Years (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • children aged between 3 and 16 years.
  • All patients are ASA physical status I or II scheduled to undergo a tonsillectomy with or without adenoidectomy using sharp dissection technique.

Exclusion Criteria

  • psychiatric illness.
  • cardiac disease.
  • renal or hepatic impairment.
  • allergy dexamethasone , paracetamol and opioids.

Arms & Interventions

group (A)

Active Comparator

will receive intravenous paracetamol 30mg/kg (max 90 mg/kg/day).

Intervention: paracetamol (Drug)

group (B)

Active Comparator

will receive dexamethasone 0.5mg/kg IV.

Intervention: Dexamethasone (Drug)

group(C)

Placebo Comparator

will received placebo 10 ml normal saline IV.

Intervention: normal Saline (Drug)

Outcomes

Primary Outcomes

Total opioid consumption at PACU

Time Frame: two hours postoperatively

total amount of opioid that will be taken by the patients postoperatively.

Secondary Outcomes

  • objective pain score(at 0 minute , 30 minutes ,1 hour and 2 hours at PACU)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Fatma Ahmed Abdel Fatah

lecturer

Benha University

Study Sites (1)

Loading locations...

Similar Trials